Patients with low acuity conditions dialling NHS 111 can now be referred to over 600community pharmacies in the North East of England.
The Community Pharmacy Referral Service (CPRS) pilot enables patients seeking advice and treatment on rashes, constipation, diarrhoea, vaginal discharge, sore eye, mouth ulcer, failed contraception, vomiting, scabies and ear wax to visit 618 pharmacies across Durham, Darlington, Tees, Northumberland and Tyne and Wear.
‘Important part’
Alastair Buxton, director of NHS Services at the Pharmaceutical Services Negotiating Committee (PSNC), said that ‘management of minor conditions has always been an important part of the community pharmacy service’.
Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
He said: ‘The service aligns well with the NHS Five Year Forward View and NHS England’s current priorities, including moving care closer to home, ‘channel shifting’ and promoting self-care’.
Launching last week (4 December), the scheme is meant to ‘increase capacity and relieve pressure’ on emergency care services.
Increasing referrals to pharmacy
Through NHS 111, pharmacies can already provide the NHS Urgent Medicines Supply Advanced Service (NUMSAS) pilot to patients.
In October 2016 and February 2017, two workshops in the North East of England identified opportunities to increase the number of referrals from NHS 111 to pharmacy.
They identified a potential to increase current pharmacy referrals from 0.1% of referrals to 10%, which represents 35,000 referrals a year in that part of the country.
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
Mr Buxton said: ‘The pilot should demonstrate how the community pharmacy network can be effectively used as part of the NHS urgent care system and it will hopefully build the case for a similar approach to be taken across the whole of England.’
How does it work?
When at the pharmacy, patients receive a face-to-face consultation and self-care advice on the management of their condition.
If treatment is needed, it can either be sold by the pharmacist or delivered through a ‘locally commissioned minor ailments scheme’.
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
But if the patient’s condition or symptom is urgent and can’t be dealt with by the pharmacist, or requires further investigation, the pharmacist will direct the patient to a ‘more appropriate care setting’, such as the patient’s general practice’.
The service will run until 31 March 2018.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.